"STAT Research is an independent clinical research site with more than 20 years of experience. We conduct FDA-approved clinical research studies for both new investigational products, as well as, post-marketing clinical research studies. Our primary area of expertise is Rheumatology, but we also have studied in immunology, acute illness, and family medicine type disorders. Interested patients may contact us and be notified of new studies for which they may qualify for."

During the past decade, STAT Research Inc conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 22 clinical trials were completed, i.e. on average, 95.7% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 11 clinical trials were completed. i.e. 110% of trials that started reached the finish line.

Out of the total clinical trials conducted in "STAT Research Inc" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Human Genome Sciences Inc." with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Allergan" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "STAT Research Inc" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Hexal AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "STAT Research Inc" are "Rheumatoid Arthritis" (10 trials), "Arthritis, Rheumatoid" (7 trials), "Arthritis, Psoriatic" (3 trials), "Diabetes Mellitus" (3 trials) and "Gastroparesis" (3 trials). Many other conditions were trialed in "STAT Research Inc" in a lesser frequency.

Most popular intervention types in "STAT Research Inc" are "Drug" (39 trials), "Biological" (5 trials) and "Other" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Belimumab 1 mg/kg" (3 trials), "Belimumab 10 mg/kg" (3 trials), "Guselkumab" (3 trials) and "Methotrexate" (3 trials). Other intervention names were less common.

The vast majority of trials in "STAT Research Inc" are 42 trials for "All" genders.

Currently, there are NaN active trials in "STAT Research Inc". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in STAT Research Inc, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in STAT Research Inc, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".